Unit 6-Drugs Affecting Endocrine System (pt 2)

CHAPTER 61: Drugs for Thyroid Disorders

THYROID HORMONES
  • Profound effect on:

    • Metabolism

    • Cardiac function

    • Growth

    • Promotes maturation in infancy and childhood

    • Development

THYROID HORMONE ACTIONS
  • Thyroid: Produces two active hormones whose synthesis is stimulated by low plasma levels of iodine:

    1. Triiodothyronine (T3)

    • Synthetic form: Liothyronine

    1. Thyroxine (T4, tetraiodothyronine)

    • Synthetic form: Levothyroxine

REGULATION OF THYROID FUNCTION
THYROID FUNCTION TESTS
  • Serum thyroid-stimulating hormone (TSH):

    • Used for screening and diagnosis of hypothyroidism.

    • Elevated TSH is an indicator of hypothyroidism.

  • Serum T4 test:

    • Can measure total T4 or free T4.

    • Used to monitor thyroid hormone replacement therapy or screen for thyroid dysfunction.

  • Serum T3 test:

    • Can measure total T3 or free T3.

    • Helpful in diagnosing hyperthyroidism and monitoring thyroid hormone replacement therapy.

HYPOTHYROIDISM IN ADULTS
  • Clinical Presentation (Moderate to Severe Disease):

    • Pale, puffy face

    • Cold, dry skin

    • Brittle hair or loss of hair

    • Lowered heart rate and temperature

    • Lethargy and fatigue

    • Intolerance to cold

    • Impaired mentality

  • Causes:

    • Usually due to malfunction of the thyroid (e.g., Hashimoto’s disease - chronic autoimmune thyroiditis)

    • Insufficient iodine in the diet

    • Surgical removal of thyroid or destruction of thyroid with radioactive iodine

    • Insufficient secretion of TSH and thyrotropin-releasing hormone (TRH)

HYPOTHYROIDISM TREATMENT IN ADULTS
HYPERTHYROIDISM IN ADULTS
  • Clinical Presentation:

    • Tachycardia

    • Nervousness, insomnia

    • Muscle weakness, atrophy

    • Intolerance to heat

    • Increased appetite

    • Unintended weight loss

TWO FORMS OF HYPERTHYROIDISM
  1. Graves’ disease:

    • Most common form, predominantly affects women aged 20 to 40 years

    • Characterized by exophthalmos

  2. Toxic nodular goiter (Plummer’s disease)

HYPERTHYROIDISM: Cause and Treatment
  • Cause:

    • Thyroid-stimulating immunoglobulins (TSIs)

  • Treatment Options:

    • Surgical removal of thyroid tissue

    • Destruction of thyroid tissue

    • Suppression of thyroid hormone synthesis

    • Beta blockers (e.g., propranolol) to manage symptoms

    • Nonradioactive iodine

THYROID HORMONE PREPARATIONS
  • Levothyroxine [Synthroid]:

    • Synthetic preparation of thyroxine (T4) and the drug of choice for hypothyroidism.

    • Converts to T3 in the body

    • Half-life: 7 days

    • Used for all forms of hypothyroidism

    • Administered orally (PO) and requires lifelong replacement therapy.

  • Administration Instructions:

    • Should be taken in the morning at least 30 to 60 minutes before breakfast

  • Adverse Effects:

    • Tachycardia

    • Angina

    • Tremors

    • Nervousness

    • Insomnia

    • Hyperthermia

    • Heat intolerance

    • Sweating

  • Drug Interactions:

    • Drugs that reduce levothyroxine absorption include H2 blockers, PPIs, sucralfate, aluminum antacids, calcium supplements, iron supplements, magnesium

    • Drugs that accelerate levothyroxine metabolism include antiepileptics and sertraline

    • Caution advised with warfarin and catecholamines

HYPERTHYROIDISM TREATMENT: METHIMAZOLE
  • Methimazole:

    • First-line drug for hyperthyroidism, prototype of the thionamides.

    • Does not cause liver damage as seen with propylthiouracil (PTU)

    • Does not destroy existing stores of thyroid hormone

    • May take 3 to 12 weeks to achieve a euthyroid state

    • More risky than PTU during lactation and first trimester of pregnancy

  • Applications in Hyperthyroidism:

    1. Sole form of therapy for Graves’ disease

    2. Adjunct to radiation therapy until the effects become manifest

    3. Suppresses thyroid hormone synthesis in preparation for subtotal thyroidectomy

    4. Treats thyrotoxic crisis

  • Adverse Effects:

    • Avoid in pregnant and breastfeeding women

    • Risk of agranulocytosis

    • Risk of hypothyroidism

RADIOACTIVE IODINE-131 (131I)
NONRADIOACTIVE IODINE
  • Strong iodine solution (Lugol’s solution):

    • Used to suppress thyroid function in preparation for thyroidectomy

  • Adverse Effects:

    • Brassy taste

    • Burning sensation in mouth and throat

    • Soreness of teeth and gums

BETA BLOCKERS
  • Propranolol:

    • Can effectively suppress tachycardia and symptoms of Graves’ disease

    • Benefits arise from beta-adrenergic blockade, not from directly reducing T3 or T4 levels

    • Beneficial in thyrotoxic crisis

CHAPTER 76: Glucocorticoids in Nonendocrine Disorders

GLUCOCORTICOID DRUGS
  • Also known as corticosteroids, nearly identical to steroids produced by the adrenal cortex (e.g., cortisol, prednisone)

  • Physiological Effects (Low Doses):

    • Maintenance of normal physiological function

  • Pharmacological Effects (High Doses):

    • Suppression of inflammation

CONTROL OF GLUCOCORTICOID SYNTHESIS AND SECRETION
PHARMACOLOGY OF GLUCOCORTICOIDS
ROUTES OF ADMINISTRATION
DOSAGE

CHAPTER 69: Drugs for Male Sexual Dysfunction and Benign Prostatic Hyperplasia

MALE SEXUAL DYSFUNCTION
  • Erectile Dysfunction (ED):

    • Persistent inability to achieve or maintain an erection suitable for sexual intercourse.

    • Affects up to 30 million men, commonly associated with chronic illnesses (diabetes, hypertension, depression)

    • Risk for ED increases with age

PHYSIOLOGY OF PENILE ERECTION
TREATMENT FOR ED
  • Drugs:

    • Oral agents include phosphodiesterase type 5 (PDE5) inhibitors (e.g., sildenafil, vardenafil, tadalafil, avanafil)

SILDENAFIL [VIAGRA]
  • PDE5 Inhibitor:

    • First oral agent for ED

    • Generally well tolerated but risky if used with certain vasodilators (alpha-adrenergic blockers and nitrates)

    • Initially developed as a cardiac medication

    • Enhances normal erectile response in the presence of stimuli

    • No significant impact on men without ED

    • Approved in 2005 as Revatio for pulmonary arterial hypertension

  • Adverse Effects:

    • Hypotension

    • Priapism

    • Headache, dyspepsia, flushing, nasal congestion, diarrhea, rash, dizziness, mild transient visual disturbances, intensification of obstructive sleep apnea

    • Rare side effects include nonarteritic ischemic optic neuropathy and sudden hearing loss

  • Pharmacokinetics:

    • Absorption is slowed by high-fat meals.

  • Drug Interactions:

    • Nitrates (risk of life-threatening hypotension)

    • Should maintain a 24-hour interval between these medications.

    • Alpha blockers — can cause symptomatic postural hypotension

    • Inhibitors of cytochrome P450 (CYP3A4) can inhibit sildenafil metabolism

VARDENAFIL, TADALAFIL, AND AVANAFIL
  • All three drugs inhibit PDE5 and are approved for oral therapy of ED.

    • Vardenafil: Prolongs QT interval

    • Tadalafil: Unique for a 36-hour effect duration

    • Avanafil: Unique for its fastest onset of action

    • Tadalafil: Approved for patients with both BPH and ED

BENIGN PROSTATIC HYPERPLASIA (BPH)
  • Nonmalignant prostate enlargement caused by excessive growth of epithelial (glandular) and smooth muscle cells.

  • Signs and Symptoms Include:

    • Urinary hesitancy

    • Urinary urgency

    • Increased frequency of urination

    • Dysuria

    • Nocturia

    • Straining to void

    • Postvoid dribbling

    • Decreased force and caliber of urinary stream

    • Sensation of incomplete bladder emptying

TREATMENT OPTIONS FOR BPH
  • Surgery

  • Watchful waiting

  • Drug therapy:

    • 5-Alpha-reductase inhibitors (mechanical obstruction):

    • Finasteride

    • Dutasteride

    • Alpha-1-adrenergic antagonists (dynamic obstruction)

FINASTERIDE [PROSCAR]
  • Mechanism: Inhibits 5-alpha-reductase

  • Most effective in patients with very large prostates (mechanical obstruction)

  • Also marketed at lower dosages as Propecia for male-pattern baldness

  • Adverse Effects:

    • Decreases ejaculate volume and libido

    • Risk of gynecomastia

    • Reduces levels of prostate-specific antigen (PSA)

ALPHA1-ADRENERGIC ANTAGONISTS
  • Five approved for treatment of benign prostatic hyperplasia (BPH):

    • Terazosin [Hytrin]

    • Doxazosin [Cardura]

    • Tamsulosin [Flomax]

    • Alfuzosin [Uroxatral]

    • Silodosin [Rapaflo]

  • Mechanism: Blockade of alpha1 receptors relaxes smooth muscle in the bladder neck (trigone and sphincter)

  • Impact on Blood Pressure:

    • Tamsulosin [Flomax] and alfuzosin [Uroxatral] are selective and have little to no effect on blood pressure.

    • Terazosin [Hytrin] and doxazosin [Cardura] block alpha receptors in blood vessels, promoting vasodilation and lowering blood pressure.

  • Adverse Effects:

    • Tamsulosin [Flomax] and alfuzosin [Uroxatral]: Less likely to cause hypotensive effects compared to terazosin and doxazosin.

    • Tamsulosin may cause abnormal ejaculation.

    • Terazosin [Hytrin] and doxazosin [Cardura]: Potential for hypotension, fainting, dizziness, somnolence, and nasal congestion.

  • Note: Drugs do not decrease PSA levels; caution is needed for cataract surgery due to risk of “floppy-iris syndrome.”

DRUG INTERACTIONS
  • Caution with other medications that lower blood pressure:

    • Organic nitrates (nitroglycerin), antihypertensive drugs, PDE5 inhibitors used for ED.